logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Phosphodiesterase 5 Inhibitor class drugs

    FiltersReset Filters
    26 results

    • adcirca

      (Tadalafil)
      United Therapeutics Corporation
      Usage: ADCIRCA® is indicated for treating pulmonary arterial hypertension (PAH) to improve exercise ability, specifically in patients with NYHA Functional Class II-III symptoms, including idiopathic, heritable PAH, and PAH associated with connective tissue diseases.

    • avanafil

      (Avanafil)
      Camber Pharmaceuticals, Inc.
      Usage: Avanafil tablets are indicated for the treatment of erectile dysfunction in adult males, functioning as a phosphodiesterase 5 (PDE5) inhibitor.

    • cialis

      (Tadalafil)
      Eli Lilly and Company
      Usage: CIALIS® is indicated for the treatment of erectile dysfunction (ED) and the signs and symptoms of benign prostatic hyperplasia (BPH). It may be used for both conditions together, but the combination treatment with finasteride should not exceed 26 weeks due to diminishing benefits.

    • revatio

      (sildenafil citrate)
      PFIZER LABORATORIES DIV PFIZER INC
      Usage: REVATIO is indicated for treating pulmonary arterial hypertension (PAH) in adults and pediatric patients aged 1 to 17 years. It aims to improve exercise ability and delay clinical worsening in adults, while in pediatrics, it also addresses pulmonary hemodynamics when standardized exercise testing isn’t feasible.

    • sildenafil

      (sildenafil)
      Advagen Pharma Ltd
      Usage: Sildenafil tablets are indicated for the treatment of erectile dysfunction.

    • sildenafil

      (Sildenafil)
      Quallent Pharmaceuticals Health LLC
      Usage: Sildenafil tablets, USP are indicated for treating pulmonary arterial hypertension (PAH) in adults, aimed at improving exercise ability and delaying clinical worsening. Pediatric usage information exists for a different formulation but is not included in this drug labeling due to marketing exclusivity.

    • sildenafil

      (Sildenafil)
      Ajanta Pharma USA Inc.
      Usage: Sildenafil for oral suspension is indicated for treating pulmonary arterial hypertension (PAH) in adults to improve exercise ability and delay clinical worsening. Pediatric information is available for a different formulation but not included in this product label due to marketing exclusivity.

    • sildenafil

      (Sildenafil)
      AvKARE
      Usage: Sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) in adults, aimed at improving exercise ability and delaying clinical worsening. Pediatric use information exists but is not included due to marketing exclusivity.

    • sildenafil citrate

      (Sildenafil)
      Advagen Pharma Ltd
      Usage: Sildenafil tablets are indicated for treating pulmonary arterial hypertension (WHO Group I) in adults, to enhance exercise ability and delay clinical worsening, particularly in those with NYHA Functional Class II-III symptoms. It should not be combined with bosentan, as it does not improve exercise capacity.

    • sildenafil citrate

      (SILDENAFIL CITRATE)
      NIVAGEN PHARMACEUTICALS, INC.
      Usage: Sildenafil tablets are indicated for the treatment of erectile dysfunction.